Hetero, a Hyderabad-based pharmaceutical today announced that it has received approval for generic Sofosbuvir Tablets, 400 mg, from the Drug Controller General of India.
Hetero will launch Sofosbuvir under its brand Sofovir in India. It will price the generic medicine at Rs 19,900/- for a bottle of 28 tablets and will launch the medicine this month in India and other countries soon.
The Pharma major has also tied up with various other Licensee holders to distribute the generic Sofosbuvir in India.
Sofosbuvir 400 mg tablets, a once-daily oral dose are being used for the treatment of chronic hepatitis C infection across the world. This is expected to usher in the beginning of a new era in Hepatitis-C treatment.
Hetero has a non-exclusive License Agreement with Gilead Sciences, Ireland to manufacture and sell generic versions of its chronic hepatitis C medicines in 91 developing countries.
"Hepatitis C is a growing public health concern, particularly in developing countries such as India and Hetero is committed to bringing affordable sofosbovir to India" said Vamsi Krishna, Director- Hetero.